Dr. Marcia Tonnesen, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 181 N Belle Mead Rd, East Setauket, NY 11733 Phone: 631-444-4200 |
Dr. Richard Clark, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 181 N Belle Mead Rd, East Setauket, NY 11733 Phone: 631-444-4200 |
Dr. Robert Seth Levine, DO Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4 Technology Dr, East Setauket, NY 11733 Phone: 631-689-3188 Fax: 732-244-2804 |
Dr. Tara Kaufmann, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 181 N. Belle Mead Road, Suite #5, East Setauket, NY 11733 Phone: 516-255-0684 |
Dr. Leonard Kristal, M.D. Dermatology - Pediatric Dermatology Medicare: Not Enrolled in Medicare Practice Location: 181 N Belle Mead Rd, East Setauket, NY 11733 Phone: 631-444-4200 |
News Archive
Inovio Pharmaceuticals, Inc. announced today that testing of multiple synthetic vaccine constructs for cytomegalovirus (CMV) induced robust T cells in mice, demonstrating the potential for a SynCon DNA vaccine to treat this virus that causes infant death and congenital abnormalities, is associated with cerebral palsy and brain tumors, and is the most common viral infection in organ transplant recipients. CMV is also associated with numerous inflammatory diseases and cancers, and is implicated in hypertension, a major risk factor for cardiovascular diseases.
Precedent Health, Inc., a healthcare company focused on aligning physicians, hospitals and payers by building innovative provider networks, today announced the formal launch of the company. Funding was provided by Heritage Group, LLC, TEXO Ventures, LLC and members of the founding executive team. The company will have its headquarters in Nashville, TN along with a satellite office in Austin, TX.
Before 2001, catastrophic craniovertebral junction (CVJ) injuries were the most common cause of death to drivers in the fast-paced sport of professional car racing. That changed with the development and implementation of the HANS (Head and Neck Support) device and similar restraints.
New research has found that the brain continues to accept ambiguous visual information about an object in motion even when it conflicts with more reliable information that we can touch.
Working with lab mice models of multiple sclerosis, UC Davis scientists have detected a novel molecular target for the design of drugs that could be safer and more effective than current FDA-approved medications against MS.
› Verified 3 days ago